IP Library › Granted Patent US 10,261,093
Granted Patent B2
US 10,261,093 · App. 14/885,460 · Granted Apr 16, 2019

Isolating cells expressing secreted proteins

Inventors: James P. Fandl (LaGrangeville, NY); Gang Chen (Yorktown Heights, NY); Neil Stahl (Carmel, NY); George D. Yancopoulos (Yorktown Heights, NY)
Assignee: Regeneron Pharmaceuticals, Inc.
G01N33/6854C12N15/65G01N33/566G01N33/56966G01N2333/7051
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,261,093
App. No.
14/885,460
Granted
Apr 16, 2019
Kind
B2
Abstract

A method of detecting and isolating cells that produce a secreted protein of interest (POI), for example, an antibody, comprising: a) providing a eukaryotic cell comprising (i) a nucleic acid encoding the POI, and (ii) a nucleic acid encoding a cell surface capture molecule, which comprises a membrane anchor and is capable of binding the POI; (b) culturing the cell under conditions in which the POI and cell surface capture molecule are expressed, and a POI-cell surface capture molecule complex is formed intracellularly and displayed on the cell surface; c) detecting the surface-displayed POI by contacting the cells with a detection molecule, which binds the POI; and d) isolating cells based on the detection molecule.

Claims (17)

1. A method of detecting or isolating a eukaryotic cell that produces an antibody, comprising:

(a) transfecting an eukaryotic cell with (i) a nucleic acid encoding an antibody heavy chain, (ii) a nucleic acid encoding an antibody light chain, and (iii) a nucleic acid encoding a cell surface capture molecule, which comprises a membrane anchor and is capable of binding the antibody;

(b) culturing the cell under conditions in which the antibody and cell surface capture molecule are expressed, and an antibody-cell surface capture molecule complex is formed intracellularly and displayed on the cell surface;

(c) contacting the cell with a detection molecule, which binds to the antibody; and

(d) detecting or isolating the cell.

2. The method of claim 1 , wherein the cell is detected in step (d) by flow cytometry.

3. The method of claim 1 , wherein the membrane anchor is a transmembrane anchor or a GPI link.

4. The method of claim 1 , wherein the detection molecule comprises two molecules that bind each other and are differentially labeled.

5. The method of claim 1 , wherein the detection molecule is linked to a solid support or particle.

6. The method of claim 1 , further comprising contacting the cell with a blocking molecule that binds the cell surface capture molecule or the antibody to block the adherence of the antibody secreted from the expressing cell to a neighboring cell.

7. The method of claim 1 , wherein the nucleic acid encoding the cell surface capture molecule is introduced into the cell before the nucleic acid encoding the antibody heavy chain and the nucleic acid encoding the antibody light chain.

8. The method of claim 7 , wherein the nucleic acid encoding the cell surface capture molecule is stably integrated in the cell.

9. The method of claim 7 , wherein the nucleic acid encoding the antibody heavy chain and the nucleic acid encoding the antibody light chain are introduced into the cell simultaneously.

10. The method of claim 9 , wherein the nucleic acid encoding the antibody heavy chain and the nucleic acid encoding the antibody light chain introduced into the cell are included in the same vector or plasmid.

11. The method of claim 9 , wherein the nucleic acid encoding the antibody heavy chain and the nucleic acid encoding the antibody light chain introduced into the cell are included in different vectors or plasmids.

12. The method of claim 1 , wherein the nucleic acid encoding the cell surface capture molecule is introduced into the cell after the nucleic acid encoding the antibody heavy chain and the nucleic acid encoding the antibody light chain.

13. The method of claim 1 , wherein the nucleic acid encoding the cell surface capture molecule is introduced into the cell simultaneously with the nucleic acid encoding the antibody heavy chain and the nucleic acid encoding the antibody light chain.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 11, 2016
From: FANDL, JAMES P.; CHEN, GANG; STAHL, NEIL; YANCOPOULOS, GEORGE
To: REGENERON PHARMACEUTICALS, INC.
Reel/Frame 037717/0695 →
Continuity (8)
Continuation 14565767 · Dec 10, 2014
Continuation 13738349 · Jan 10, 2013
Continuation 12240541 · Sep 29, 2008
Continuation In Part 11434403 · May 15, 2006
Continuation 11099158 · Apr 5, 2005
Division 10050279 · Jan 16, 2002
Provisional Application 60261999 · Jan 16, 2001
Related Publication 20160033530A1 · Feb 4, 2016